Jallal Bahija (CIK 1730038) reported 4 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-05-15). Recent activity: Buy ELV (563 shares), Buy IMCR (23,817 shares), Sell IMCR (11,474 shares), Buy ELV (601 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-15 | Elevance Health, Inc. (ELV) | Director | Buy | 563 | $0 |
| 2026-02-19 | Immunocore Holdings plc (IMCR) | CHIEF EXECUTIVE OFFICER | Buy | 23,817 | $0 |
| 2026-02-19 | Immunocore Holdings plc (IMCR) | CHIEF EXECUTIVE OFFICER | Sell | 11,474 | $371,184 |
| 2025-05-16 | Elevance Health, Inc. (ELV) | Director | Buy | 601 | $0 |
Source: SEC Form 4 filings · as of 2026-05-15